Compound ID | 2718
Class: Rifamycin
| Agent Type: | Semisynthetic; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | RNA synthesis inhibitor. Targets DNA-dependent RNA polymerase (RNA synthesis inhibitor) |
| Target Pathogen: | Active against Staphylococcus aureus |
| Description: | Semisynthetic compound; dimeric rifamycin |
| Institute where first reported: | Department for Antibiotics and Natural Products of Lepetit; Laboratori di Microbiologia, Gruppo Lepetit S.p.A., Via Durando 38, 1-20158 Milano, Italy |
| Year first mentioned: | 1975 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/275180757 |
| Citation: | https://febs.onlinelibrary.wiley.com/doi/10.1111/j.1432-1033.1975.tb04007.x |